Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.
about
Inhibition of PAR-4 and P2Y12 receptor-mediated platelet activation produces distinct hepatic pathologies in experimental xenobiotic-induced cholestatic liver disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of PAR-4 and P2Y12 ...... ced cholestatic liver disease.
@en
Inhibition of PAR-4 and P2Y12 ...... ced cholestatic liver disease.
@nl
type
label
Inhibition of PAR-4 and P2Y12 ...... ced cholestatic liver disease.
@en
Inhibition of PAR-4 and P2Y12 ...... ced cholestatic liver disease.
@nl
prefLabel
Inhibition of PAR-4 and P2Y12 ...... ced cholestatic liver disease.
@en
Inhibition of PAR-4 and P2Y12 ...... ced cholestatic liver disease.
@nl
P2093
P2860
P1433
P1476
Inhibition of PAR-4 and P2Y12 ...... uced cholestatic liver disease
@en
P2093
Anna K Kopec
James P Luyendyk
Jessica L Ray
P2860
P356
10.1016/J.TOX.2016.07.021
P407
P50
P577
2016-07-27T00:00:00Z